VeriMomresorcinol bis-ethylhexanoate hamilelikte güvenli mi?
Searches of regulatory and literature databases (ECHA registration/C&L, PubMed, CIR, CosIng, EWG) did not identify a harmonised CLP classification, an EU Annex II/III restriction, SCCS/CIR safety assessment, or peer‑reviewed reproductive/developmental studies for 'resorcinol bis‑(2‑ethylhexanoate)' (or close name variants). In the absence of reproductive or endocrine‑activity data and with no EU ban/restriction, hazard and mechanism are scored 0. Exposure is scored 1 (low but measurable) because the compound is an organic, lipophilic ester (typical cosmetic esters have at least low dermal absorption). Sources searched did not return evidence of reproductive hazard.
Related ingredients
Frequently asked questions
- resorcinol bis-ethylhexanoate hamilelikte güvenli mi?
- Searches of regulatory and literature databases (ECHA registration/C&L, PubMed, CIR, CosIng, EWG) did not identify a harmonised CLP classification, an EU Annex II/III restriction, SCCS/CIR safety assessment, or peer‑reviewed reproductive/developmental studies for 'resorcinol bis‑(2‑ethylhexanoate)' (or close name variants). In the absence of reproductive or endocrine‑activity data and with no EU ban/restriction, hazard and mechanism are scored 0. Exposure is scored 1 (low but measurable) because the compound is an organic, lipophilic ester (typical cosmetic esters have at least low dermal absorption). Sources searched did not return evidence of reproductive hazard.
- resorcinol bis-ethylhexanoate emzirirken güvenli mi?
- No evidence found for reproductive or lactation-specific toxicity or mechanistic endocrine activity. By analogy with topical cosmetic esters, low but measurable maternal absorption could allow minimal transfer to breastmilk; therefore exposure scored 1. No authoritative sources (EU Annex, harmonised H‑code, SCCS/CIR) indicate restriction for lactation.
- resorcinol bis-ethylhexanoate bebek cildi için güvenli mi?
- No infant-specific toxicology or clinical safety data were located. Following your rule to increase exposure by +1 for baby skin when the adult exposure is measurable, baby exposure is scored 2 (moderate) because infants have higher surface‑area‑to‑weight and an immature barrier. Hazard and mechanism remain 0 in the absence of data showing reproductive, developmental, or endocrine activity.
- VeriMom resorcinol bis-ethylhexanoate nasıl puanlıyor?
- VeriMom resorcinol bis-ethylhexanoate'yi EU CosIng, ECHA sınıflandırmaları ve PubMed çalışmalarına göre 93/100 (bilinen risk yok) olarak puanlar.
- Hamilelikte resorcinol bis-ethylhexanoate yerine neler kullanılabilir?
- Benzer işlevli ve bilinen riski olmayan alternatifleri içeren listemize bakın.
Her etiketi 2 saniyede kontrol et
VeriMom'u ücretsiz indirin — herhangi bir ürünü tarayın ve hamilelik güvenlik puanını anında görün.
Tıbbi Sorumluluk Reddi
Bu bilgiler yalnızca eğitim amaçlıdır ve tıbbi tavsiye niteliği taşımaz. Güvenlik puanları kamuya açık verilere dayanmaktadır ve tüm riskleri yansıtmayabilir. Hamilelik veya emzirme döneminde herhangi bir ürünü kullanmadan önce her zaman sağlık uzmanınıza danışın.